The global neurovascular devices market will grow from $3.32b in 2024 to $7.01b by 2035, achieving a CAGR of 7.02%, according ...

According to the group, upright proton therapy offers a faster pre-treatment setup, with patients in a vertical position.

Kenanga Research expects investor sentiment on Bursa Malaysia to remain positive in the fourth quarter while foreign ...

Bursa Malaysia extended last week’s losses to close lower on Monday, mirroring the mainly negative regional trend, with ...